Lung Research and Innovation Group (LRIG)

Bringing lung research and innovation together to speak as one voice and raise the profile of lung conditions.

Experts across the respiratory sector have come together to form the Lung Research and Innovation Group, also known as LRIG.

Email to get in touch with LRIG and hear more about their work.

Fixing Lung Health in the UK - 10 priorities

LRIG have mapped 10 priorities the government and other researcher funders must take to urgently accelerate respiratory research and innovation.

Find out more and download the report

LRIG is made up of expert organisations and individuals determined to drive progress in lung research and deliver better outcomes for people living with a lung condition. The group is convened by Asthma + Lung UK and co-chaired by Dr Samantha Walker, Director of Research and Innovation at A+LUK, and Professor Ian Hall, University of Nottingham.

More investment in research and innovation is urgently needed to prevent, diagnose, treat and manage lung conditions better, and to give people better quality, longer lives. We want to triple public and private investment in lung research and innovation to £150 million.

LRIG’s priorities are to:

  • Map the research landscape to identify gaps in lung research and innovation to identify new opportunities for investment.
  • Promote collaboration so that funding allocated to lung research and innovation is used efficiently to maximise patient benefit and to boost the UK life sciences sector.
  • Encourage the funders of lung research and innovation, such as industry, charitable and Governmental funders, to increase investment in respiratory projects to at least £150 million per year.

Members of LRIG  

  • Action for Pulmonary Fibrosis
  • Association of British Health Tech Industries
  • The Association of the British Pharmaceutical Industry
  • Asthma + Lung UK (Conveners)
  • British Association for Lung Research
  • British Thoracic Society
  • Cystic Fibrosis Trust
  • Engineering and Physical Sciences Research Council
  • LifeArc
  • Medical Research Council
  • NHS England
  • NIHR
  • NIHR Respiratory Translational Research Collaboration
  • Office for Life Sciences
  • The Primary Care Respiratory Society
  • Pulmonary Fibrosis Trust
  • Sarcoidosis UK

Research Advisors 

  • Professor Eric Alton, Imperial College London
  • Dr Lisa Brighton, King's College London
  • Dr Hannah Durrington, University of Manchester
  • Professor Clare Lloyd, Imperial College London
  • Professor Jenni Quint, Imperial College London
  • Professor Cliff Taggart, Queen's University Belfast